Glucose tolerance factor extracted from yeast: Oral insulin-mimetic and insulin-potentiating agent: In vivo and in vitro studies

British Journal of Nutrition

Volumn 108, Issue 5, 2012, Pages 875-882

  Weksler Zangen, Sarah ^a   Mizrahi, Tal ^b   Raz, Itamar ^a   Mirsky, Nitsa ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

Author keywords

Diabetes; Glucose tolerance factor; Glucose lowering effect; Insulin signalling; Yeast

Indexed keywords

FUNGAL EXTRACT; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; METHANOL; MITOGEN ACTIVATED PROTEIN KINASE; ORAL ANTIDIABETIC AGENT; PROTEIN KINASE B; AMINO ACID; CHROMIUM; NICOTINIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INTRACELLULAR SIGNALING; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; RAT; YEAST; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; ISOLATION AND PURIFICATION; MOLECULAR MIMICRY; ORAL DRUG ADMINISTRATION; PHOSPHORYLATION;

ADMINISTRATION, ORAL; AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; CELL LINE; CHROMIUM; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; INSULIN; MALE; MOLECULAR MIMICRY; NICOTINIC ACIDS; PHOSPHORYLATION; RATS; YEASTS;

EID: 84871859211     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006167     Document Type: Article

References (27)

1. Malviya N, Jain S & Malviya S (2010) Antidiabetic potential of medicinal plants. Acta Pol Pharm 67, 113-118.
2. Samad A, Shams MS, Ullah Z, et al. (2009) Status of herbal medicines in the treatment of diabetes: a review. Curr Diabetes Rev 5, 102-111.
3. Smirin P, Taler D, Abitbol G, et al. (2010) Sarcopoterium spinosum extract as an antidiabetic agent: in vitro and in vivo study. J Ethnopharmacol 129, 10-17.
4. Bjornholm M & Zierath JR (2005) Insulin signal transduction in human skeletal muscles: identifying the defects in Type II diabetes. Biochem Soc Trans 33, 354-357.
5. Schwarz K & Mertz W (1957) A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys 72, 515-518.
6. Holdsworth ES & Neville E (1990) Effects of extracts of highand low-chromium brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high-or low-Cr diets. Br J Nutr 63, 623-630.
7. Mertz W & Schwarz K (1959) Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets. Am J Physiol 196, 614-618.
8. Tokuda M, Kashiwagi A, Wakamiya E, et al. (1987) Glucose tolerance factor stimulates 3-O-methylglucose transport into isolated rat adipocytes. Biochem Biophys Res Commun 144, 1237-1242.
9. Tuman RW & Doisy RJ (1977) Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26, 820-826.
10. Tuman RW, Bilbo JT & Doisy RJ (1978) Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes 27, 49-56.
11. Mirsky N, Weiss A & Dori Z (1980) Chromium in biological systems, I. Some observations on glucose tolerance factor in yeast. J Inorg Biochem 13, 11-21.
12. Mirsky N, Weiss A & Dori Z (1981) The effect of glucose tolerance factor in glucose uptake by yeast cells. J Inorg Biochem 15, 275-279.
13. Mirsky N (1993) Glucose tolerance factor reduces blood glucose and free fatty acids levels in diabetic rats. J Inorg Biochem 49, 123-128.
14. Weksler-Zangen S, Yagil C, Zangen DH, et al. (2001) The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes 50, 2521-2529.
15. Weksler-Zangen S, Raz I, Lenzen S, et al. (2008) Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat. Diabetes 57, 279-287.
16. Davies DM, Holdsworth ES & Sherriff JL (1985) The isolation of glucose tolerance factors from brewer's yeast and their relationship to chromium. Biochem Med 33, 297-311.
17. Haylock SJ, Buckley PD & Blackwell LF (1983) The relationship of chromium to the glucose tolerance factor. II. J Inorg Biochem 19, 105-117.
18. Toepfer EW, Mertz W, Polansky MM, et al. (1976) Preparation of chromium-containing material of glucose tolerance factor activity from brewer's yeast extracts and by synthesis. J Agric Food Chem 25, 162-166.
19. Mertz W (1975) Effects and metabolism of glucose tolerance factor. Nutr Rev 33, 129-135.
20. Nakhoul F, Abassi Z, Morgan M, et al. (2006) Inhibition of diabetic nephropathy in rats by an oral antidiabetic material extracted from yeast. J Am Soc Nephrol 17, S127-S131.
21. Grant AP & McMullen JK (1982) The effect of brewers yeast containing glucose tolerance factor on the response to treatment in type 2 diabetics. A short controlled study. Ulster Med J 51, 110-114.
22. Evans GW, Roginski EE & Mertz W (1973) Interaction of the glucose tolerance factor (GTF) with insulin. Biochem Biophys Res Commun 50, 718-722.
23. Fischer Y, Thomas J, Rose H, et al. (1992) Alanine and hyperosmolarity are responsible for the stimulation of cardiomyocyte glucose transport by samples containing a glucose tolerance factor. Life Sci 50, 1963-1972.
24. Mertz W (1993) Chromium in human nutrition: a review. J Nutr 123, 626-633.
25. Haylock SJ, Buckley PD & Blackwell LF (1983) Separation of biologically active chromium-containing complexes from yeast extracts and other sources of glucose tolerance factor (GTF) activity. J Inorg Biochem 18, 195-211.
26. Simonoff M, Shapcott D, Alameddine S, et al. (1992) The isolation of glucose tolerance factors from brewer's yeast and their relation to chromium. Biol Trace Elem Res 32, 25-38.
27. Berdicevsky I & Mirsky N (1994) Effects of insulin and glucose tolerance factor (GTF) on growth of Saccharomyces cerevisiae. Mycoses 37, 405-410.